Efficacy of Combined Oral L-ornithine-L-aspartate and Lactulose in Patients With Hepatic Encephalopathy
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
Hypothesis: Is the combination of oral L-ornithine-L-aspartate and lactulose more efficacious
than oral lactulose alone in treatment of hepatic encephalopathy? Study design; Randomized,
double-blinded, placebo controlled trial